1032TiP A phase I, first-in-human, study of TILT-123, a tumor-selective oncolytic adenovirus encoding TNFa and IL-2, in participants with advanced melanoma receiving adoptive T-cell therapy with tumor-infiltrating lymphocytes

Subjects

Subjects :

Oncolytic adenovirus
Tumor-infiltrating lymphocytes
business.industry
T cell
Hematology
First in human
Tilt (optics)
medicine.anatomical_structure
Oncology
Cancer research
medicine
Tumor necrosis factor alpha
business
Advanced melanoma

Details

ISSN :

09237534

Volume :

32

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........d656355903674448c4ae445350b84bb2

Full Text :

https://doi.org/10.1016/j.annonc.2021.08.1416